TLPH

Talphera Inc

• NASDAQ·3d ago

  Talphera (TLPH) Upgraded to Buy: Here's What You Should Know

• TipRanks·08/24 00:23

  Talphera Earnings Call Highlights Nafamostat Momentum

• TipRanks·08/14 13:00

  Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT)

• Seeking Alpha·08/13 15:51

  Talphera falls despite narrower Q2 loss, NEPHRO trial progress

• TipRanks·08/13 10:30

  Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Talphera (TLPH) and Cognition Therapeutics (CGTX)

• Seeking Alpha·08/12 20:10

  Talphera GAAP EPS of -$0.06 beats by $0.01

• Seeking Alpha·08/12 14:00

  Here are the major earnings after the close Wednesday

• PR Newswire·08/05 20:05

  Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

• TipRanks·06/23 21:20

  Talphera Shareholders Approve Directors and Governance Proposals

• TipRanks·06/06 09:01

  Dollar Tree, Onto, Chipotle, Lululemon, Talphera Trending

• Dow Jones·06/05 12:51

  Talphera Price Target Announced at $3.00/Share by HC Wainwright & Co.

• Dow Jones·06/05 12:51

  Talphera Coverage Assumed by HC Wainwright & Co. at Buy

• TipRanks·06/05 10:27

  Talphera assumed with a Buy at H.C. Wainwright

• TipRanks·05/20 00:27

  Talphera Earnings Call Highlights NEPHRO Trial Momentum

• NASDAQ·05/19 16:14

  Talphera Reports Q1 Loss Of $2 Mln; Completes 50% Enrolment In Phase 3 Trial